We conducted a retrospective observational study in patients with laboratory-confirmed COVID-19 who received medical care in 688 COVID-19. Patients were categorized into 8 groups (<20, 20-29, 30-39, 40-49, 50-59, 60-69, 70-79, and 80 years). Symptoms at initial presentation were classified according to a previously validated classification into respiratory and non-respiratory symptoms. Comparisons between time from symptom onset to medical care for every age category were done through ANOVA. Logistic regression were applied to determine the risk of presenting symptoms of severity according to age. 286020 patients were included (mean age: 42.8, SD:16.8 years). Mean time from symptom onset to medical care was 4.04 (SD:3.6) days and increased with older age categories (p<0.0001). The risk of presenting with symptoms of severity was greater with increasing age categories (20-29: OR=1.65, 95%CI:1.59-1.71; 30-39: OR=1.96, 95%CI:1.89-2.03, 40-49: OR=2.05, 95%CI:1.98-1.2.16, 50-59: OR=2.05, 95%CI:1.98-2.16, 60-69: OR=2.35, 95%CI:2.26-2.45, 70-79: OR=2.82, 95%CI:2.67-2.97, and 80 years: OR=3.27, 95%CI:3.01-3.55).
We conducted a retrospective observational study in patients with laboratory-confirmed coronavirus disease (COVID-19) who received medical care in 688 COVID-19 ambulatory units and hospitals in Mexico City between 24 February 2020 and 24 December 2020, to study if the elderly seek medical care later than younger patients and their severity of symptoms at initial medical evaluation. Patients were categorised into eight groups (<20, 20–29, 30–39, 40–49, 50–59, 60–69, 70–79 and ≥80 years). Symptoms at initial evaluation were classified according to a previously validated classification into respiratory and non-respiratory symptoms. Comparisons between time from symptom onset to medical care for every age category were performed through variance analyses. Logistic regression models were applied to determine the risk of presenting symptoms of severity according to age, and mortality risk according to delays in medical care. In total, 286 020 patients were included (mean age: 42.8, s.d.: 16.8 years; 50.4% were women). Mean time from symptom onset to medical care was 4.04 (s.d.: 3.6) days and increased with older age categories (P < 0.0001). Mortality risk increased by 6.4% for each day of delay in medical care from symptom onset. The risk of presenting with the symptoms of severity was greater with increasing age categories. In conclusion, COVID-19 patients with increasing ages tend to seek medical care later, with higher rates of symptoms of severity at initial presentation in both ambulatory units and hospitals.
We conducted a retrospective observational study in patients with laboratoryconfirmed COVID-19 who received medical care in 688 COVID-19 ambulatory units and hospitals in Mexico City between 24 February 2020 and 24 December 2020, to study history of exposition to confirmed COVID-19 cases, time-to-ambulatory care, time-to-hospitalization, and severity of symptoms at first medical contact, according to age. Patients were categorized into 8 groups (<20, 20-29, 30-39, 40-49, 50-59, 60-69, 70-79, and 80 years). Symptoms at initial presentation were classified according to a previously validated classification into respiratory and non-respiratory symptoms. Comparisons between time from symptom onset to medical care for every age category were done through variance analyses. Two logistic regression models were applied to determine the risk of presenting symptoms of severity according to age. 286020 patients were included (mean age: 42.8, SD: 16.8 years; 50.4% were women). Mean time from symptom onset to medical care was 4.04 (SD: 3.6) days and increased with older age categories (p<0.0001). The risk of presenting with symptoms of severity was greater with increasing age categories (20-29:
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.